Literature DB >> 10837785

Blood substitutes.

R M Winslow1.   

Abstract

Red cell substitutes are a group of oxygen carriers designed to temporarily replace transfused blood. Each product is unique in its limitations and advantages. Research and development has been slow because of the far-reaching consequences of replacing an oxygen carrier outside of the red cell. Nevertheless, a number of products are in advanced clinical trials and nearing the market. When they are available for use it is likely that development will accelerate and even better products will substantially alleviate the world-wide shortage of blood for transfusion and enable the delivery of medical care to underserved populations. An important consequence of the development of these products has been a better understanding of how oxygen is delivered to tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837785     DOI: 10.1016/s0169-409x(99)00045-9

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  10 in total

1.  Preparation and characterization of dimeric bovine hemoglobin tetramers.

Authors:  Tao Hu; Dongxia Li; Zhiguo Su
Journal:  J Protein Chem       Date:  2003-07

2.  A Nanomotor-Based Active Delivery System for Intracellular Oxygen Transport.

Authors:  Fangyu Zhang; Jia Zhuang; Berta Esteban Fernández de Ávila; Songsong Tang; Qiangzhe Zhang; Ronnie H Fang; Liangfang Zhang; Joseph Wang
Journal:  ACS Nano       Date:  2019-09-30       Impact factor: 15.881

3.  Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin.

Authors:  Tao Hu; Belur N Manjula; Dongxia Li; Michael Brenowitz; Seetharama A Acharya
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 4.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

5.  Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes.

Authors:  Xiaolan Zhang; Changsheng Liu; Yuan Yuan; Shiyu Zhang; Xiaoqian Shan; Yan Sheng; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2008-01-25       Impact factor: 3.896

6.  Mathematical model of NO and O2 transport in an arteriole facilitated by hemoglobin based O2 carriers.

Authors:  Sharon Irene Gundersen; Guo Chen; Andre Francis Palmer
Journal:  Biophys Chem       Date:  2009-02-21       Impact factor: 2.352

7.  In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.

Authors:  Yan Sheng; Yuan Yuan; Changsheng Liu; Xinyi Tao; Xiaoqian Shan; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-04-14       Impact factor: 3.896

8.  Low modulus biomimetic microgel particles with high loading of hemoglobin.

Authors:  Kai Chen; Timothy J Merkel; Ashish Pandya; Mary E Napier; J Christopher Luft; Will Daniel; Sergei Sheiko; Joseph M DeSimone
Journal:  Biomacromolecules       Date:  2012-08-17       Impact factor: 6.988

Review 9.  Effects of hemoglobin-based oxygen carriers on blood coagulation.

Authors:  Kimia Roghani; Randall J Holtby; Jonathan S Jahr
Journal:  J Funct Biomater       Date:  2014-12-12

10.  Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy.

Authors:  Wenguang Wang; Yuhao Cheng; Peng Yu; Haoran Wang; Yue Zhang; Haiheng Xu; Qingsong Ye; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Nat Commun       Date:  2019-04-05       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.